Hannu J. Aronen

Turku, Finland

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 54 publications

Lifestyle, anthropometric factors and clinically significant prostate cancer diagnosis in men with suspected prostate cancer.

Lifestyle, anthropometric factors and clinically significant prostate cancer diagnosis in men with suspected prostate cancer.

Journal: Scandinavian journal of urology

Published: February 11, 2026

AI detection of knee joint effusion from radiographs: Comparative accuracy of two commercial algorithms.

AI detection of knee joint effusion from radiographs: Comparative accuracy of two commercial algorithms.

Journal: European journal of radiology open

Published: January 09, 2026

Comparative accuracy of two commercial AI algorithms for musculoskeletal trauma detection in emergency radiographs.

Comparative accuracy of two commercial AI algorithms for musculoskeletal trauma detection in emergency radiographs.

Journal: Emergency radiology

Published: April 11, 2025

Prospective comparison of 18F-PSMA-1007 PET/CT and MRI with histopathology as the reference standard for intraprostatic tumour detection and T-staging of high-risk prostate cancer.

Prospective comparison of 18F-PSMA-1007 PET/CT and MRI with histopathology as the reference standard for intraprostatic tumour detection and T-staging of high-risk prostate cancer.

Journal: European journal of nuclear medicine and molecular imaging

Published: January 02, 2025

Correction: Huhtanen et al. Discrepancies between Radiology Specialists and Residents in Fracture Detection from Musculoskeletal Radiographs. Diagnostics 2023, 13, 3207.

Correction: Huhtanen et al. Discrepancies between Radiology Specialists and Residents in Fracture Detection from Musculoskeletal Radiographs. Diagnostics 2023, 13, 3207.

Journal: Diagnostics (Basel, Switzerland)

Published: November 09, 2024

Long-Term Risk of Clinically Significant Prostate Cancer in Biopsy-Negative Patients With Baseline Biparametric Prostate MRI.

Long-Term Risk of Clinically Significant Prostate Cancer in Biopsy-Negative Patients With Baseline Biparametric Prostate MRI.

Journal: Journal of magnetic resonance imaging : JMRI

Published: July 19, 2024

Differences in Gut Microbiota Profiles and Microbiota Steroid Hormone Biosynthesis in Men with and Without Prostate Cancer.

Differences in Gut Microbiota Profiles and Microbiota Steroid Hormone Biosynthesis in Men with and Without Prostate Cancer.

Journal: European urology open science

Published: February 14, 2024

Relaxation Along a Fictitious Field, continuous wave T1rho, adiabatic T1rho and adiabatic T2rho imaging of human gliomas at 3T: A feasibility study.

Relaxation Along a Fictitious Field, continuous wave T1rho, adiabatic T1rho and adiabatic T2rho imaging of human gliomas at 3T: A feasibility study.

Journal: PloS one

Published: September 26, 2023

Discrepancies between Radiology Specialists and Residents in Fracture Detection from Musculoskeletal Radiographs.

Discrepancies between Radiology Specialists and Residents in Fracture Detection from Musculoskeletal Radiographs.

Journal: Diagnostics (Basel, Switzerland)

Published: September 04, 2023

Diagnosis of prostate cancer with magnetic resonance imaging in men treated with 5-alpha-reductase inhibitors.

Diagnosis of prostate cancer with magnetic resonance imaging in men treated with 5-alpha-reductase inhibitors.

Journal: World journal of urology

Published: June 27, 2023

Individualised non-contrast MRI-based risk estimation and shared decision-making in men with a suspicion of prostate cancer: protocol for multicentre randomised controlled trial (multi-IMPROD V.2.0).

Individualised non-contrast MRI-based risk estimation and shared decision-making in men with a suspicion of prostate cancer: protocol for multicentre randomised controlled trial (multi-IMPROD V.2.0).

Journal: BMJ open

Published: April 16, 2022

The Mount Sinai Prebiopsy Risk Calculator for Predicting any Prostate Cancer and Clinically Significant Prostate Cancer: Development of a Risk Predictive Tool and Validation with Advanced Neural Networking, Prostate Magnetic Resonance Imaging Outcome Database, and European Randomized Study of Screening for Prostate Cancer Risk Calculator.

The Mount Sinai Prebiopsy Risk Calculator for Predicting any Prostate Cancer and Clinically Significant Prostate Cancer: Development of a Risk Predictive Tool and Validation with Advanced Neural Networking, Prostate Magnetic Resonance Imaging Outcome Database, and European Randomized Study of Screening for Prostate Cancer Risk Calculator.

Journal: European urology open science

Published: April 14, 2022

Showing 1-12 of 54

Last Updated: 09/26/2026